Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 414-422

  Quabius, Elgar Susanne ^a   Haag, Jochen ^a   Kühnel, André ^a   Henry, Hannes ^a   Hoffmann, Anna Sophie ^b   Görögh, Tibor ^a   Hedderich, Jürgen ^a   Evert, Matthias ^c   Beule, Achim G ^c   Maune, Steffen ^d   Knecht, Rainald ^e   Òvári, Attila ^f   Durisin, Martin ^g   Hoppe, Florian ^h   Tribius, Silke ^e   Röcken, Christoph ^a   Ambrosch, Petra ^a   Hoffmann, Markus ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h KLINIKUM OLDENBURG   (Germany)

Author keywords

E6mRNA; E7mRNA; Geography; Head and neck squamous cell carcinoma; Human papillomavirus; P16INK4A

Indexed keywords

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMPLICATION; FEMALE; GENETIC VARIABILITY; GENETICS; GEOGRAPHY; GERMANY; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PREVALENCE; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC VARIATION; GEOGRAPHY; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 84917690553     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2697     Document Type: Article

References (41)

1. Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269, 2008.
2. Gillison ML, Koch WM, Capone RB, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720, 2000.
3. Klussmann JP, Weissenborn SJ, Wieland U, et al: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884, 2001.
4. Kreimer AR, Clifford GM, Boyle P, et al: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475, 2005.
5. Ang KK, J. Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35, 2010.
6. Smith EM, Ritchie JM, Summersgill KF, et al: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108: 766-772, 2004.
7. Holzinger D, Schmitt M, Dyckhoff G, et al: Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res 72: 4993-5003, 2012.
8. Hoffmann M, Ihloff AS, Görögh T, et al: p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 127: 1595-1602, 2910.
9. Hoffmann M, Tribius S, Quabius ES, et al: HPV DNA, E6(∗) I-mRNA expression and p16(INK4A) immunohistochemistry in head and neck cancer - How valid is p16(INK4A) as surrogate marker? Cancer Lett 323: 88-96, 2012.
10. Shi W, Kato H, Perez-Ordonez B, et al: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 27: 6213-6221, 2009.
11. Smeets SJ, Hesselink AT, Speel E-JM, et al: A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121: 2465-2472, 2007.
12. Wiest T, Schwarz E, Enders C, et al: Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510-1517, 2002.
13. Attner P, Du J, Näsman A, et al: Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 128: 2892-2897, 2011.
14. Tribius S, Ihloff AS, Rieckmann T, et al: Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know. Cancer Lett 304: 71-79, 2011.
15. Hoffmann M, Görögh T, Gottschlich S, et al: Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 218: 199-206, 2005.
16. Straetmans JM, Olthof N, Mooren JJ, et al: Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 119: 1951-1957, 2009.
17. Hoffmann M, Kahn T, Mahnke CG, et al: Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Otolaryngol 118: 138-144, 1998.
18. Näsman A, Attner P, Hammarstedt L, et al: Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125: 362-366, 2009.
19. Termine N, Panzarella V, Falaschini S, et al: HPV in oral squamous cell carcinoma vs. head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 19: 1681-1690, 2008.
20. Pannone G, Rodolico V, Santoro A, et al: Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization. Infect Agent Cancer 7: 4, 2012, doi:10.1186/1750-9378-7-4.
21. Holzinger D, Flechtenmacher C, Henfling N, et al: Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway. Int J Cancer 133: 1389-1400, 2013.
22. Kostareli E, Holzinger D, Bogatyrova O, et al: HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J Clin Invest 123: 2488-2501, 2013.
23. Reuschenbach M, Clad A, von Knebel Doeberitz C, et al: Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results. Gynecol Oncol 119: 98-105, 2010.
24. Reuschenbach M, Kansy K, Garbe K, et al: Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany. Oral Oncol 49: 937-942, 2013.
25. Remmerbach TW, Brinckmann UG, Hemprich A, et al: PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 30: 302-208, 2004.
26. Quabius ES, Ossenkop L, Harder S and Kern M: Dental implants stimulate expression of Interleukin-8 and its receptor in human blood - An in vitro approach. J Biomed Mater Res B Appl Biomater 100: 1283-1288, 2012.
27. Halec G, Schmitt M, Dondog B, et al: Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 132: 63-71, 2013.
28. Klaes R, Friedrich T, Spitkovsky D, et al: Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284, 2001.
29. Gillison ML, D'Souza G, Westra W, et al: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100: 407-420, 2008.
30. Weiss D, Koopmann M and Rudack C: Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck 33: 856-862, 2011.
31. Hoffmann M, Gottschlich S, Görögh T, et al: Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Otolaryngol 125: 415-4121, 2005.
32. Hoffmann M, Orlamünder A, Sucher J, et al: HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers. Anticancer Res 26: 663-670, 2006.
33. Hoffmann M, Klose N, Gottschlich S, Görögh T, Fazel A, Lohrey C, et al: Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Lett 239: 64-70, 2006.
34. Hoffmann M, Scheunemann D, Fazel A, et al: Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma. Oncol Rep 21: 809-814, 2009.
35. Chaturvedi AK, Engels EA, Pfeiffer RM, et al: Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29: 4294-4301, 2011.
36. Chung CH and Gillison ML: Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 15: 6758-6762, 2009.
37. Klussmann JP, Mooren JJ, Lehnen M, et al: Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15: 1779-1786, 2009.
38. Liang C, Marsit CJ, McClean MD, et al: Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 72: 5004-5013, 2012.
39. Lassen P, Eriksen JG, Hamilton-Dutoit S, et al: Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 27: 1992-1998, 2009.
40. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, et al: HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol 94: 30-35, 2010.
41. O'Sullivan B, Hui Huang S, Siu LL et al: Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 31: 543-550, 2013.